| Title : Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease - Del Cerro_2018_CNS.Drugs_32_579 |
| Author(s) : Del Cerro P , Alquezar C , Bartolome F , Gonzalez-Naranjo P , Perez C , Carro E , Paez JA , Campillo NE , Martin-Requero A |
| Ref : CNS Drugs , 32 :579 , 2018 |
| Abstract : Del Cerro_2018_CNS.Drugs_32_579 |
| ESTHER : Del Cerro_2018_CNS.Drugs_32_579 |
| PubMedSearch : Del Cerro_2018_CNS.Drugs_32_579 |
| PubMedID: 29736745 |
Del Cerro P, Alquezar C, Bartolome F, Gonzalez-Naranjo P, Perez C, Carro E, Paez JA, Campillo NE, Martin-Requero A (2018)
Activation of the Cannabinoid Type 2 Receptor by a Novel Indazole Derivative Normalizes the Survival Pattern of Lymphoblasts from Patients with Late-Onset Alzheimer's Disease
CNS Drugs
32 :579
Del Cerro P, Alquezar C, Bartolome F, Gonzalez-Naranjo P, Perez C, Carro E, Paez JA, Campillo NE, Martin-Requero A (2018)
CNS Drugs
32 :579